Page last updated: 2024-08-21

nsc 65346 and Cytomegalic Inclusion Disease

nsc 65346 has been researched along with Cytomegalic Inclusion Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernier-Rodriguez, M; Drach, JC; Kern, ER; Krawczyk, SH; Nassiri, MR; Townsend, LB; Wotring, LL1
Alaghamandan, HA; Frank, KB; McKernan, PA; Ramasamy, K; Revankar, GR; Robins, RK; Smee, DF1

Other Studies

2 other study(ies) available for nsc 65346 and Cytomegalic Inclusion Disease

ArticleYear
Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:12

    Topics: Animals; Antiviral Agents; Arabinonucleosides; Cell Division; Chemical Phenomena; Chemistry; Cytomegalovirus; Cytomegalovirus Infections; Humans; Leukemia L1210; Mice; Molecular Structure; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Toyocamycin; Tumor Cells, Cultured

1990
Antiviral activities of 2'-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses.
    Antiviral research, 1988, Dec-11, Volume: 10, Issue:6

    Topics: Adenoviridae; Animals; Antiviral Agents; Cell Division; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; DNA Viruses; Friend murine leukemia virus; Herpes Simplex; Humans; Leukemia, Experimental; Mice; Molecular Structure; Pyrimidine Nucleosides; Retroviridae; Simplexvirus; Tumor Cells, Cultured; Vero Cells; Visna-maedi virus

1988